Unlikely to cause harm — often a labeling or packaging issue.
Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
| Brand name | BUSPIRONE HYDROCHLORIDE, LISINOPRIL |
| Generic name | BUSPIRONE HYDROCHLORIDE, LISINOPRIL |
| Active ingredient(s) | BUSPIRONE HYDROCHLORIDE, LISINOPRIL |
| Distributed by / for | NCS Healthcare of Kentucky Inc |
| NDC | 0615-7718-05 |
| Full product label | Lisinopril Tablets USP 20 mg, packaged in a) 15-count blister card (NDC 0615-7718-05), b) 30-count blister card (NDC 0615-8255-39), Rx only, Mfd By Lupin, PKG by Vangard Glasgow, KY 42141. |
| Recalling firm | NCS Healthcare of Kentucky Inc |
| Distribution | Nationwide USA |
| Quantity | 12 cards |
| Recall initiated | 2023-10-27 |
| Report date | 2023-11-29 |
| Recall completed | 2024-07-14 |
| Recall number | D-0114-2024 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Glasgow KY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗